USPTO serial 76551720
COMBIDOSE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARDY LUDLOW, TARAH KIM
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COMBIDOSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles E. Weinstein, Esq.
Charles E. Weinstein, Esq. Foley Hoag LLP155 Seaport BoulevardBoston, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATION, NAMELY, A DRUG DELIVERY SYSTEM FOR A TWO-COMPONENT DRUG FORMULATION IN THE FORM OF A TABLET FOR RAPID RELEASE OF ONE COMPONENT IN THE MOUTH AND RELEASE OF THE OTHER COMPONENT UPON SWALLOWING, USED FOR THE TREATMENT OF PAIN, CARDIOVASCULAR DISORDERS, MENTAL DISORDERS, CASTRO-INTESTINAL DISORDERS, MITSCULAR DISORDERS, NEUROLOGICAL DISORDERS, DIGESTIVE DISORDERS, SKELETO-MUSCULAR DISORDERS, KIDNEY DISEASE, UROLOGICAL DISORDERS, CANCER, SARCOMAS, MYELOMAS, BLOOD DISEASES, FACIAL DISORDERS, MOUTH AND NASAL DISORDERS, EYE DISEASES, BRIAN DISORDERS, LIVER DYSFUNCTION, SKIN DISORDERS, PANCREATAL DISORDERS, RHINITIS, ALLERGY, ORAL DISORDERS, IMFLAMMATION, DEPRESSION, ANXIETY, SLEEP DISORDERS, RESPIRATORY DISEASES, ENDOCRINE DYSFUNCTIONS, ACNE, INFECTION, COLDS, FERTILITY DISORDERS, NAUSEA, MENSTRUAL PROBLEMS, EATING DISORDERS, AND LUNG DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS- Buprenorphine, Butorphanol, Fenoprofen, Flurbiprofen, Diflunisal, Naproxen, Ibuprofen, Potassium Diclofenac, Fentanyl, Sodium Diclofenac, Parecoxib, Valdecoxib, Ketorolac, Tramadol, Aceclofenac, Acetaminophen, Acetanilide, Aiphaprodine, Codeine, Dihydrocodeine, Dihydromorphine, Hydrocodone, Hydromorphone, Indoprofen, Ketoprofen, Ketorolac, Levorphanol, Loxoprofen, Meperidine, Methadone, Morphine, Naloxone, Pentazocine, Norlevorphanol, Oxycodone, Oxymorphone, Phenazocine, Propoxyphene, Tramadol, Zomepirac, Zolpidem, Zaleplon, Bupropion, Lorazepam, Buspirone, Ipsapirone, Gepirone, Triazolam, Nitrazepam, Estazolam, Diazepam, Oxazepam, Acetazolamide, Amiloride, Butazolamide, Clofenamide, Disulfamide, Ethacrynic Acid, Ethiazide, Ethoxzolamide, Etozolin, Fenquizone, Furosemide, Hydrochiorothiazide, Quinethazone, Torsemide, Triamterene, Cyproheptadine, Acravistine, Azatadine Maleate, Brompheniramine, Dextromethorphan, Carinoxamine Maleate, Chiorpheniramine, Descarboxyethyloratadine, Fexofenadine, Loratadine, Clemastine, Pseudoephedrine, Dexbrompheniramine, Diphenhydramine, Norastemizole, Doxylamine, Ketotifen, Prometha-zine, Tripelennamine, Plaunotol, Rosaprostol, Rotraxate, Spizofurone, Teprenone, Troxipide, Zolimidine, Temelastine, Naratriptan, Dizatriptan, Frovatriptan, Zolmitriptan, Sumatriptan, Almotriptan, Rizatriptan, Propanolol, Atenolol, Amitryptyline, Nortriptyline, Doxepin, Verapamil, Amlodipine, Ergotamine Tartrate, Caffeine, Dihydroergotamine, Bupropion, Methyiphenidate, Captopril, Clonidine, Betaxolol, Bisoprolol, Nitroglycerin, Isorbide Mononitrate, Isosorbide Dinitrate, Bufuralol, Furosemide, Guanabenz, Guanfacine, Hydralazine, Labetalol, Metoprolol, Nadolol, Nifedipine, Oxprenolol, Pindolol, Sotalol, Timolol, Bunitrolol, Indecaimide, Nadoxolol, Penbutolol, Tocainide, Hydrochiorothiazide, Furosemide, Granisetron, Odansetron, Prochiorperazine, Metoclopramide, Clonazepam, Vigabatrin, Sildenafil, Aiprostadil, Fentanyl, Sufentanil, Lofentanil, Carfentanil, Alfentanil, Pentacozine, Nalbuphine, Ketamine, Droperidol, Haloperidol, Valium, Midazolam, Lorazepam, Etomidate, Pentathol, Methohexitol, Deprivan, Propanidid, Minoxalone, Rofecoxib, Fenoprofen, Flurbiprofen, Diflunisal, Naproxen, Ibuprofen, Indomethacin, Etodolac, Sulindac, Fentanyl, Sodium Diclofenac, Celecoxib, Parecoxib, Valdecoxib, Ketorolac, Tramadol, Aceclofenac, Acetaminophen, Acetanilide, Acetylsalcylsalicylic Acid, Aiphaprodine, Aspirin, Bermoprofen, Naprosyn, Codeine, dihydrocodeine, Dihydromorphine, Hydrocodone, Hydromorphone, Indoprofen, Ketoprofen, Ketorolac, Levorphanol, Loxoprofen, Mefenamic Acid, Meperidine, Methadone, Morphine, Nabumetone, Pentazocine, Norlevorphanol, Normethadone (N-desmethyl-methadone), Normorphine (N-desmethyl-morphine), Oxycodone, Oxymorphone, Phenazocine, Propoxyphene, Salsalate, Suprofen, Tramadol, Zomepirac, Zolpidem, Zaleplon, Zopiclone, Hydroxyzine, Trazodone, Citalopram, Lorazepam, Buspirone, Ipsapirone, Gepirone, Triazolam, Nitrazepam, Estazolam, Diazepam, Oxazepam, Acetazolamide, Amanozine, Amiloride, Benzylhydrochlorothiazide, Bumetanide, Buthiazide, Chiorothiazide, Clofenamide, Clopamide, Clorexolone, Cyclothiazide, Disulfamide, Ethacrynic Acid, Ethiazide, Ethoxzolamide, Etozolin, Fenquizone, Furosemide, Hydracarbazine, Hydrochiorothiazide, Hydroflumethiazide, Indapamide, Mefruside, Methazolaznide, Methyclothiazide, Metolazone, Pamabrom, Torsemide, Trimterene, Xipamide, Spironolac-tone, Cyproheptadine, Meclizine, Brompheniraniine, Dextromethorphan, Citirizine, Chiorpheniramine, Descarboxyethyloratidine, Fexofenadine, Loratadine, Pseudoephedrine, Dexbrompheniramine, Diphenhydra-mine, Norastemizole, Doxylamine, Ketotifen, Promethazine, Tripelennamine, Cimedtidine, Famotidine, Lansoprazole, Nizatidine, Omeprazole, Pantoprazole, Pirenzepine, Plaunotol, Ranitidine, Rebamipide, Rioprostil, Roxatidine Acetate, Telenzepine, Troxipide, Zolmidine, O-Desmethyl astemizole, Acrivastine, Temelastine, Naratriptan, Dizatriptan, Zolmitriptan, Sumatriptan, Almotriptan, Eletriptan, Rizatriptan, Propanolol, Atenolol, Amitryptyline, Nortriptyline, Doxepin, Verapamil, Amlodipine, Ergotamine tartrate, Caffeine, Dihydroergotamine, Amoxapine, Bupropion, Citalopram, Clomipramine, Desipramine, Doxepin, Fluoxetine, Fluvoxaniine, Paroxetine, Trazodone, Vanlafaxine, d-amphetamine, Captopril, Enalapril, Lisinopril, Quinapril, Acebutolol, Benzapril, Nitroglycerin, Isorbide Mononitrate, Isosorbide Dinitrate, Bupranolol, Corvedilol, Condesortan, Diltiazem, Doxazosin, Felodipine, Fosinopril, Furosemide, Guanabenz, Guranfacine, Hydralazine, Indopamide, Irbesarton, Labetalol, Isradepine, Linopril, Losarton, Metolazone, Metoprolol, Mibefradil, Moexipril, Nadolol, Nicardipine, Nifedipine, Nisoldipine, Oxprenolol, Pindolol, Prazosin, Propranolol, Quinapril, Rampipril, Sotalol, Telmisartan, Temocapril, Terazosin, Trandolapril, Valsartan, Verapamil, Amiodarone, Aprindine, Bufetolol, Eunitrolol, Practolol, Propafenone, Quinidine Sulphate, Tocainide, Bumetanide, Loperamide, Granistron, Dolasetron Mesylate, Ondansetron, Dexamethasone, Prochlorperazine, Metoclopramide, Gabapenten, Carbamazepine, Clonazepam, Lamotrigine, Phenytoin, Tigabine, Vigabatrin, Sildenafil, Papaverine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HIRSH, MARK
- Other trademarks owned by HIRSH, MARK
- Other trademarks owned by COLLEGIUM PHARMACEUTICAL, INC.
- Other trademarks in Class 005
- Similar marks named COMBIDOSE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2008 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 27, 2008 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 25, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 19, 2008 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 28, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 28, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 28, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 28, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 5, 2007 | NEWN | NEW NOA TO ISSUE | — |
| Jun 8, 2007 | PGRN | PETITION GRANTED - ISSUE NEW NOA | — |
| Apr 10, 2007 | PAPER RECEIVED | — | |
| Mar 17, 2007 | PINM | INCOMPLETE PETITION NOTICE MAILED | — |
| Mar 17, 2007 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 22, 2007 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Jan 22, 2007 | PAPER RECEIVED | — | |
| Jan 3, 2007 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 3, 2007 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 2, 2006 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 2, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 15, 2006 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Mar 15, 2006 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jan 19, 2006 | PAPER RECEIVED | — | |
| Nov 12, 2004 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Aug 2, 2004 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jul 13, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 23, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| May 5, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2004 | PAPER RECEIVED | — | |
| Apr 20, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 1, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2004 | DOCK | ASSIGNED TO EXAMINER | — |